Ftse Mib
33.707,21
-0,38%
DAX
18.177,62
-0,90%
S&P 500
5.469,30
0,39%
NASDAQ
17.717,65
1,26%
Bitcoin
61.738,90
-0,10%
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Elutia Inc (ELUT) Elutia Inc (ELUT) Notizie

Elutia Inc

ELUT
3,80
-0,11 (-2,81%)
25 Giu 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
18/6/202422:15EDGAR2Form 8-K - Current report
17/6/202414:30EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
17/6/202414:15EDGAR2Form 8-K - Current report
17/6/202414:01GLOBEElutia Announces $13.26 Million Registered Direct Offering
17/6/202414:00GLOBEElutia Announces FDA Clearance of EluPro®: The First..
10/6/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/6/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/6/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/6/202423:00EDGAR2Form 8-K - Current report
13/5/202423:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/5/202414:00GLOBEElutia to Showcase BioEnvelope Product Line at Heart Rhythm..
09/5/202423:26EDGAR2Form 8-K - Current report
09/5/202422:05GLOBEElutia Announces First Quarter 2024 Results: SimpliDerm®..
02/5/202422:05GLOBEElutia to Report First Quarter 2024 Financial Results on..
24/4/202422:05GLOBEElutia to Present at the Planet MicroCap Showcase: VEGAS..
11/3/202414:15EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
07/3/202422:24EDGAR2Form 8-K - Current report
07/3/202422:05GLOBEElutia Reports Fourth Quarter and Full Year 2023 Financial..
22/2/202422:05GLOBEElutia to Report Fourth Quarter and Full Year 2023 Financial..
14/2/202422:40EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
02/2/202422:30EDGAR2Form 8-K - Current report
25/1/202422:56EDGAR2Form S-8 - Securities to be offered to employees in employee..
12/1/202423:00EDGAR2Form 8-K - Current report
10/1/202423:00EDGAR2Form 8-K - Current report
10/1/202422:05GLOBEElutia Regains Compliance with Nasdaq Listing Requirements
09/1/202422:17EDGAR2Form SC 13D/A - General statement of acquisition of..
08/1/202422:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/12/202322:30EDGAR2Form 8-K - Current report
18/12/202314:00GLOBEElutia Submits CanGarooRM® Antibiotic-Eluting Biomatrix for..
08/12/202322:04EDGAR2Form 8-K - Current report
05/12/202322:54EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
05/12/202306:15EDGAR2Form EFFECT - Notice of Effectiveness
20/11/202322:53EDGAR2Form S-3 - Registration statement under Securities Act of..
20/11/202322:02EDGAR2Form 8-K - Current report
15/11/202323:26EDGAR2Form 8-K - Current report
13/11/202322:05GLOBEElutia Reports 26% Year-Over-Year Sales Growth of..
09/11/202315:19EDGAR2Form 8-K - Current report
09/11/202314:30GLOBEElutia Completes Divestiture of Orthobiologics Business Unit..
07/11/202322:04EDGAR2Form 8-K - Current report
06/11/202322:05GLOBEElutia to Report Third Quarter 2023 Financial Results on..
18/10/202314:00PRNUSSWK Holdings Highlights Recent Achievements and Provides..
06/10/202321:28EDGAR2Form SC 13D/A - General statement of acquisition of..
05/10/202322:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/9/202322:05EDGAR2Form 8-K - Current report
20/9/202314:30GLOBEElutia to Participate in a Panel Discussion at the Cantor..
19/9/202314:36GLOBEElutia Announces Private Placement for Proceeds Up to $26..
19/9/202314:30EDGAR2Form 8-K - Current report
18/9/202322:08GLOBEElutia Announces Sale of Orthobiologics Business Unit for..
08/9/202314:30GLOBEElutia to Present at the H.C. Wainwright 25th Annual Global..
06/9/202322:05GLOBEAziyo Biologics Rebrands as Elutia to Reflect Strategic..
Apertura: 3,92 Min: 3,71 Max: 4,3199
Chiusura: 3,91

La tua Cronologia

NASDAQ
ELUT
Elutia
EU
CRHBD
Caisse De Refinancement ...
TSXV
GASX.WT.A
NG Energy
BIT
P1Y193
NLBNPIT1Y193 20991231 21...
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network